🔴 Corcept Therapeutics is trading 4.01% down today — no clear catalyst identified

Corcept Therapeutics is trading 4.01% down at $110.31, with no clear company-specific catalyst identified.

• No clear company-specific announcement, filing, earnings update, or analyst action dated September 11, 2026, was identified in available coverage.
• Recent results were broadly positive: second-quarter 2026 revenue was $256.1 million, up 31.7% year over year, making them an unlikely explanation.
• Major indexes are up roughly 1%, so market direction does not explain the decline; confidence remains low pending a potential delayed disclosure.